Who owns the ANITAC trademark?

The ANITAC trademark is owned by ESSA Pharma Inc..

What is the serial number for ANITAC?

The USPTO serial number for ANITAC is 79355612.

What is the registration number for ANITAC?

ANITAC is registered under USPTO registration number 7245195.

ANI

USPTO Trademark Record

ABANDONED

ANITAC

Q: What class is the ANITAC trademark registered in?

The ANITAC trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 79355612·Reg 7245195·Filed Jul 15, 2022

Owner ESSA Pharma Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

ANITAC (Serial No. 79355612), Registration No. 7245195, is a abandoned US trademark filed on Jul 15, 2022 by ESSA Pharma Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

ANITAC (Reg. #7245195) is an abandoned US trademark that was filed in 2022 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 3 opposition proceedings during prosecution.

FILED

Jul 15, 2022

SERIAL

79355612

REG#

7245195

REGISTERED

Dec 19, 2023

Owner

Applicant

ESSA Pharma Inc.

Entity

Not Provided

State

Address

999 West Broadway, Suite 720, Vancouver BC V5Z 1K5

Country

Attorney

NameSusan Piascik Christoff

Law firm

Susan Piascik Christoff Cooley LLP

Docket

319435-20011

Address

1299 Pennsylvania Avenue, NW, Suite 700, Washington, DC 20004, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateJul 15, 2022

Serial Number79355612

Registration No.7245195

Registration DateDec 19, 2023

Status DateMar 20, 2026

Published for OppositionOct 03, 2023

Mark TypeStandard characters

Attorney Docket319435-20011

Status DescriptionUS registration is dead and cancelled

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 3× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

27 events

DEATH OF INTERNATIONAL REGISTRATION

Jan 01, 2026

DEATH OF INTERNATIONAL REGISTRATION

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

Jan 01, 2026

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

FINAL DECISION TRANSACTION PROCESSED BY IB

Apr 23, 2024

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Apr 01, 2024

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Apr 01, 2024

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Mar 19, 2024

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Dec 19, 2023

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Dec 19, 2023

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NOTIFICATION PROCESSED BY IB

Oct 04, 2023

NOTIFICATION PROCESSED BY IB

PUBLISHED FOR OPPOSITION

Oct 03, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Oct 03, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Sep 13, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Sep 13, 2023

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Sep 13, 2023

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 28, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 25, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 25, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 25, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Jul 11, 2023

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Jun 19, 2023

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jun 19, 2023

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

May 12, 2023

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

May 11, 2023

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

May 02, 2023

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Nov 22, 2022

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 18, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Nov 17, 2022

SN ASSIGNED FOR SECT 66A APPL FROM IB

ANITAC

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by ESSA Pharma Inc.

Other Marks by Susan Piascik Christoff

Resources

Company